BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21497042)

  • 1. Evaluation of the Xpert™ MRSA/SA Blood Culture assay for the detection of Staphylococcus aureus including strains with reduced vancomycin susceptibility from blood culture specimens.
    Kelley PG; Grabsch EA; Farrell J; Xie S; Montgomery J; Mayall B; Howden BP
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):404-7. PubMed ID: 21497042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and implementation of the GeneXpert MRSA/SA blood culture assay in a pediatric setting.
    Spencer DH; Sellenriek P; Burnham CA
    Am J Clin Pathol; 2011 Nov; 136(5):690-4. PubMed ID: 22031306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Xpert MRSA/SA blood culture assay on the Gene Xpert® Dx System for rapid detection of Staphylococcus aureus and coagulase-negative staphylococci in patients with staphylococcal bacteremia.
    Biendo M; Mammeri H; Pluquet E; Guillon H; Rousseau F; Canarelli B; Belmekki M; Eb F
    Diagn Microbiol Infect Dis; 2013 Feb; 75(2):139-43. PubMed ID: 23273338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the next-generation Xpert MRSA/SA BC assay and the GeneOhm StaphSR assay to routine culture for identification of Staphylococcus aureus and methicillin-resistant S. aureus in positive-blood-culture broths.
    Buchan BW; Allen S; Burnham CA; McElvania TeKippe E; Davis T; Levi M; Mayne D; Pancholi P; Relich RF; Thomson R; Ledeboer NA
    J Clin Microbiol; 2015 Mar; 53(3):804-9. PubMed ID: 25540397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of real-time PCR Xpert MRSA/SA on GeneXpert(®) DX System in the investigation of staphylococcal bacteremia].
    Scanvic A; Courdavault L; Sollet JP; Le Turdu F
    Pathol Biol (Paris); 2011 Apr; 59(2):67-72. PubMed ID: 20832193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical validation of the molecular BD GeneOhm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures.
    Stamper PD; Cai M; Howard T; Speser S; Carroll KC
    J Clin Microbiol; 2007 Jul; 45(7):2191-6. PubMed ID: 17522275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low colonization prevalence of Staphylococcus aureus with reduced vancomycin susceptibility among patients undergoing hemodialysis in the San Francisco Bay area.
    Eguia JM; Liu C; Moore M; Wrone EM; Pont J; Gerberding JL; Chambers HF
    Clin Infect Dis; 2005 Jun; 40(11):1617-24. PubMed ID: 15889359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures.
    Pape J; Wadlin J; Nachamkin I
    J Clin Microbiol; 2006 Jul; 44(7):2575-6. PubMed ID: 16825383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
    Steinkraus G; White R; Friedrich L
    J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-saving algorithm for rapid diagnosis of Staphylococcus aureus and susceptibility to oxacillin directly from positive blood culture bottles by combined testing with BinaxNOW® S. aureus and Xpert MRSA/SA Assay.
    Yossepowitch O; Dan M; Kutchinsky A; Gottesman T; Schwartz-Harari O
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):352-5. PubMed ID: 24503507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.
    Moreillon P; Bizzini A; Giddey M; Vouillamoz J; Entenza JM
    J Antimicrob Chemother; 2012 Mar; 67(3):652-60. PubMed ID: 22167243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.
    Bennett JW; Murray CK; Holmes RL; Patterson JE; Jorgensen JH
    Diagn Microbiol Infect Dis; 2008 Apr; 60(4):437-40. PubMed ID: 18096352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.
    Kelley PG; Gao W; Ward PB; Howden BP
    J Antimicrob Chemother; 2011 May; 66(5):1057-60. PubMed ID: 21393156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    Sader HS; Jones RN; Rossi KL; Rybak MJ
    J Antimicrob Chemother; 2009 Nov; 64(5):1024-8. PubMed ID: 19744978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for Staphylococcus aureus with a reduced susceptibility to vancomycin in: a Belgian hospital].
    Piérard D; Vandenbussche H; Verschraegen I; Lauwers S
    Pathol Biol (Paris); 2004 Oct; 52(8):486-8. PubMed ID: 15465269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.